Total Payments
$3,450
2024 Payments
$245.21
Companies
34
Transactions
230
Medicare Patients
2,041
Medicare Billing
$96,056
Payment Breakdown by Category
Food & Beverage$3,172 (91.9%)
Education$278.39 (8.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,172 | 210 | 91.9% |
| Education | $278.39 | 20 | 8.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $527.44 | 32 | $0 (2024) |
| ABBVIE INC. | $524.38 | 34 | $0 (2024) |
| Amgen Inc. | $442.24 | 21 | $0 (2021) |
| PFIZER INC. | $423.42 | 33 | $0 (2024) |
| Duchesnay USA Incorporated | $244.41 | 25 | $0 (2019) |
| AMAG Pharmaceuticals, Inc. | $158.22 | 10 | $0 (2020) |
| Hologic, LLC | $139.82 | 12 | $0 (2022) |
| Aspira Women's Health Inc | $92.07 | 1 | $0 (2021) |
| Evofem Biosciences, Inc. | $67.89 | 4 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $62.30 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $245.21 | 14 | PFIZER INC. ($58.29) |
| 2023 | $311.51 | 22 | Astellas Pharma US Inc ($79.02) |
| 2022 | $167.70 | 11 | ABBVIE INC. ($94.17) |
| 2021 | $474.65 | 26 | AbbVie Inc. ($200.67) |
| 2020 | $98.59 | 7 | Astellas Pharma US Inc ($29.56) |
| 2019 | $619.66 | 46 | Astellas Pharma US Inc ($130.94) |
| 2018 | $613.06 | 37 | Amgen Inc. ($194.80) |
| 2017 | $919.82 | 67 | PFIZER INC. ($218.90) |
All Payment Transactions
230 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: VACCINES | ||||||
| 12/10/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Diagnostics | ||||||
| 11/07/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: UROLOGY | ||||||
| 10/31/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: HORMONE THERAPY | ||||||
| 10/24/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: VACCINES | ||||||
| 10/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Biological | ||||||
| 09/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: UROLOGY | ||||||
| 09/25/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Hematology | ||||||
| 08/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Biological | ||||||
| 03/27/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: Oncology | ||||||
| 02/21/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: CONTRACEPTIVE | ||||||
| 02/20/2024 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Urology | ||||||
| 01/24/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: VACCINES | ||||||
| 11/30/2023 | PFIZER INC. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 11/08/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Biological | ||||||
| 10/26/2023 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: VACCINES | ||||||
| 10/25/2023 | ABBVIE INC. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: WOMENS HEALTH | ||||||
| 08/25/2023 | ABBVIE INC. | ORILISSA (Drug), LO LOESTRIN FE | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: WOMENS HEALTH | ||||||
| 08/03/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Biological | ||||||
| 06/14/2023 | MILLICENT US INC | INTRAROSA (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 06/01/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Biological | ||||||
| 05/17/2023 | Becton, Dickinson and Company | BD Onclarity (Device) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Diagnostic Testing | ||||||
| 05/08/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Oral Contraceptive | ||||||
| 04/12/2023 | ABBVIE INC. | ORILISSA (Drug), LO LOESTRIN FE | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 476 | 476 | $45,945 | $20,483 |
| 2022 | 8 | 520 | 563 | $55,588 | $25,420 |
| 2021 | 7 | 529 | 530 | $53,255 | $25,174 |
| 2020 | 8 | 516 | 518 | $51,974 | $24,979 |
Total Patients
2,041
Total Services
2,087
Medicare Billing
$96,056
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Office | 2023 | 98 | 98 | $17,640 | $10,260 | 58.2% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 97 | 97 | $6,790 | $4,261 | 62.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 66 | 66 | $9,900 | $2,173 | 21.9% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 97 | 97 | $5,141 | $1,495 | 29.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 93 | 93 | $4,929 | $1,427 | 28.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 14 | $1,050 | $464.28 | 44.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 11 | 11 | $495.00 | $402.71 | 81.4% |
| 77067 | Screening mammography | Office | 2022 | 104 | 104 | $18,720 | $11,504 | 61.5% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 103 | 103 | $7,210 | $4,748 | 65.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 13 | 56 | $4,480 | $2,531 | 56.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 70 | 70 | $10,500 | $2,417 | 23.0% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 98 | 98 | $5,194 | $1,596 | 30.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 98 | 98 | $5,194 | $1,568 | 30.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 20 | 20 | $3,300 | $614.57 | 18.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 14 | $990.00 | $441.20 | 44.6% |
| 77067 | Screening mammography of both breasts | Office | 2021 | 107 | 107 | $19,260 | $12,599 | 65.4% |
| 77063 | Screening digital tomography of both breasts | Office | 2021 | 108 | 108 | $7,560 | $5,373 | 71.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 74 | 74 | $11,100 | $2,638 | 23.8% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 105 | 105 | $5,565 | $1,769 | 31.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 105 | 105 | $5,565 | $1,762 | 31.7% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 17 | 17 | $2,805 | $598.40 | 21.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 14 | $1,400 | $435.41 | 31.1% |
| 77067 | Mammography of both breasts | Office | 2020 | 101 | 101 | $18,180 | $12,469 | 68.6% |
| 77063 | Screening digital tomography of both breasts | Office | 2020 | 101 | 101 | $7,070 | $5,171 | 73.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 69 | 69 | $10,350 | $2,501 | 24.2% |
About Dr. David Mckee, MD
Dr. David Mckee, MD is a Obstetrics & Gynecology healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962469973.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Mckee, MD has received a total of $3,450 in payments from pharmaceutical and medical device companies, with $245.21 received in 2024. These payments were reported across 230 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($3,172).
As a Medicare-enrolled provider, Mckee has provided services to 2,041 Medicare beneficiaries, totaling 2,087 services with total Medicare billing of $96,056. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Birmingham, AL
- Active Since 04/26/2006
- Last Updated 10/27/2011
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1962469973
Products in Payments
- LO LOESTRIN FE (Drug) $291.58
- Prolia (Biological) $216.13
- Osphena (Drug) $198.20
- Myrbetriq (Drug) $195.88
- PREMARIN ORALS (Drug) $174.70
- MYRBETRIQ (Drug) $138.72
- EVENITY (Biological) $111.40
- MAKENA (Drug) $103.68
- Orilissa (Drug) $100.94
- PREMARIN (Drug) $98.55
- OVA1 (Device) $92.07
- Veozah (Drug) $88.48
- ABRYSVO (Biological) $75.94
- INTRAROSA (Drug) $70.40
- Phexxi (Drug) $67.89
- Kyleena (Drug) $62.30
- APTIMA (Device) $60.94
- PVC (Drug) $56.63
- CONTRAVE (Drug) $53.83
- Saxenda (Drug) $53.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Birmingham
Dr. Theodore Tsaltas, M.d, M.D
Obstetrics & Gynecology — Payments: $663,738
Obstetrics & Gynecology $663,738
Dr. Tomeka Roberts, Md, MD
Obstetrics & Gynecology — Payments: $43,618
Obstetrics & Gynecology $43,618
William Hudson, Md, MD
Obstetrics & Gynecology — Payments: $42,664
Obstetrics & Gynecology $42,664
Percy Hudson, Md, MD
Obstetrics & Gynecology — Payments: $31,863
Obstetrics & Gynecology $31,863
Brandy Patterson, M.d, M.D
Obstetrics & Gynecology — Payments: $29,561
Obstetrics & Gynecology $29,561
Cynthia Brown, Md, MD
Obstetrics & Gynecology — Payments: $22,131
Obstetrics & Gynecology $22,131